The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on February 16, 2026 for Renosen Pharmaceuticals Pvt Ltd
SENORES · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Renosen Pharmaceuticals Private Limited (formerly Senores Lifesciences Pvt Ltd), a promoter entity of Senores Pharmaceuticals, has released a pledge on 4,00,000 equity shares (about 0.87% of total share capital). The pledge was originally created in favor of Bajaj Finance Limited. The release was executed on February 13, 2026, and the disclosure was filed with BSE and NSE on February 16, 2026. After this release, Renosen Pharmaceuticals holds 27,08,719 shares (5.88% of capital) with zero pledged shares remaining. The pledge was linked to a loan, and its release suggests the obligation has been fulfilled.
Positive for shareholders — the release removes the overhang of potential forced selling and indicates the promoter entity has likely repaid the loan to Bajaj Finance, improving its balance sheet position.